Capstone Investment Advisors’s Roivant Sciences ROIV Stock Holding History

Capstone Investment Advisors’s Portfolio ROIV Stock Details ROIV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$258K	Buy	+7,300	New	+$216K	﹤0.01%	1528
2025 Q4	–	Sell	-101,595	Closed	-$1.54M	–	1979
2025 Q3	$1.54M	Buy	+101,595	New	+$1.26M	﹤0.01%	869
2024 Q3	–	Sell	-17,504	Closed	-$185K	–	2164
2024 Q2	$185K	Buy	+17,504	New	+$192K	﹤0.01%	1787
2024 Q1	–	Sell	-15,126	Closed	-$170K	–	2514
2023 Q4	$170K	Buy	+15,126	New	+$147K	﹤0.01%	1826

Other funds holding ROIV

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

QVT Financial New York $1.7B AUM 173.77% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

FCM

Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return

Capstone Investment Advisors's ROIV Position: Q2 2026 in Review

Capstone Investment Advisors opened a new position in Roivant Sciences (ROIV) in Q2 2026: 7,300 shares worth $258K. The stake represents ﹤0.01% of the portfolio and ranks #1528 among its holdings. This is a return to the name: Capstone Investment Advisors previously reported a position in ROIV as recently as Q3 2025.

Capstone Investment Advisors first reported a position in ROIV in Q4 2023 and has held it in 4 quarters since. The position peaked at $1.54M in Q3 2025. 498 funds tracked by Wall St. Rank hold ROIV as of Q2 2026.

Capstone Investment Advisors held 7,300 shares of Roivant Sciences worth $258K as of Q2 2026.
Roivant Sciences was a new Capstone Investment Advisors position in Q2 2026.
Roivant Sciences made up ﹤0.01% of Capstone Investment Advisors's portfolio in Q2 2026, its #1528 holding.
Capstone Investment Advisors first reported a position in Roivant Sciences in Q4 2023 and has held it in 4 quarters since.
Capstone Investment Advisors's Roivant Sciences position peaked at $1.54M in Q3 2025.
498 funds tracked by Wall St. Rank held Roivant Sciences as of Q2 2026.

Based on Capstone Investment Advisors's 13F filing for Q2 2026, filed 17 Aug 2026.